It is strictly intended for laboratory and investigational use only
This data informs adjustments to keep your healing optimized
A: In a 2023 Phase 2 trial, participants on the highest dose (12 mg) lost an average of 24.2% of their body weight over 48 weeks, and they had not yet reached a weight loss plateau
Patent Filing Patterns by Innovation Category Examining patent activity from 2020 through 2025 reveals clear directional trends across innovation categories, even without precise filing counts
But it has merit thanks to compounds like caffeine, antioxidants and add-ins such as MCT oil, fiber and protein
One of the key consumer shifts that we are beginning to see with increased GLP-1 drug adoption is the desire for smaller portioned, more nutrient-dense foods, says Jim Taschetta, COO of Givaudan entity MISTA